Editas Medicine stock price
에디타스 메디신NASDAQ:EDIT · Nasdaq · Healthcare$2.62+3.97%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Editas Medicine last closed at $2.62 (+3.97%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -4.2×. Its overall grade ranks 352 of 739 stocks in Healthcare.
About this company
Editas Medicine last closed at $2.62 (+3.97%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 352/739
Valuation grade B-
Related stocks
- CRISPR TherapeuticsCompetitor
CRISPR 기반 유전자편집 치료제 개발 경쟁사
- Intellia TherapeuticsCompetitor
CRISPR 유전자편집 플랫폼 경쟁사
- Vertex PharmaceuticalsCustomer
유전자편집 치료제 공동개발·상업화 파트너
About Editas Medicine
- What technical signals does Editas Medicine (EDIT) have?
- Editas Medicine current technical signals: no active technical signal.
- Is Editas Medicine a cup-and-handle pattern?
- No. Editas Medicine has no valid Cup signal right now.
- What published figures are available for Editas Medicine?
- Market cap: $255.76M. Trailing 12 months PER: -4.2×. Latest quarter PBR: 2.97×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Editas Medicine, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy